UnitedHealth Group subsidiary Optum—which agreed to acquire Baton Rouge’s home health care company Amedisys for roughly $3.3 billion in June—is now facing a federal antitrust lawsuit from a California health system. Emanate Health is accusing Optum of pressuring the system not to compete with Optum in the primary care business, and of steering patients away
Amedisys buyer facing antitrust lawsuit in California
Sign up for the free Daily Report email – local news about the people, companies and issues that impact business impact business in Baton Rouge and beyond.
